The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

CVS Health Corp

NYSE: CVS
Last

(U.S.) $93.85

Today's change-0.19 -0.20%
Updated July 26 4:01 PM EDT. Delayed by at least 15 minutes.
 

CVS Health Corp

NYSE: CVS
Last

(U.S.) $93.85

Today's change-0.19 -0.20%
Updated July 26 4:01 PM EDT. Delayed by at least 15 minutes.

CVS Health Corp down (U.S.)$0.19

CVS Health Corp closed lower Tuesday, dropping (U.S.)$0.19 or 0.20% to (U.S.)$93.85. Over the last five days, shares have lost 3.15% and are down 4.01% for the last year to date. This security has underperformed the S&P 500 by 19.37% during the last year.

Key company metrics

  • Open(U.S.) $94.20
  • Previous close(U.S.) $94.04
  • High(U.S.) $94.45
  • Low(U.S.) $93.39
  • Bid / Ask(U.S.) $93.70 / (U.S.) $93.99
  • YTD % change-4.01%
  • Volume4,901,096
  • Average volume (10-day)3,998,907
  • Average volume (1-month)5,030,384
  • Average volume (3-month)4,714,474
  • 52-week range(U.S.) $81.37 to (U.S.) $113.65
  • Beta0.81
  • Trailing P/E20.36×
  • P/E 1 year forward16.15×
  • Forward PEG1.08×
  • Indicated annual dividend(U.S.) $1.70
  • Dividend yield1.81%
  • Trailing EPS(U.S.) $4.61
Updated July 26 4:01 PM EDT. Delayed by at least 15 minutes.
S&P TSX0.36%Sector:Non-Cyclical Consumer Goods & ServicesIndustry:Retail - Drugs
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q1/2016Q4/2015Q3/2015Q2/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedMar 31, 201603/31/2016Dec 31, 201512/31/2015Sep 30, 201509/30/2015Jun 30, 201506/30/2015
Revenue43,21541,14638,64437,169
Total other revenue--------
Total revenue43,21541,14638,64437,169
Gross profit6,7447,3016,6616,402
Total cost of revenue36,47133,84531,98330,767
Total operating expense41,03938,41736,31334,907
Selling / general / administrative4,5684,5724,3304,140
Research & development--------
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)--00--
Other operating expenses, total--------
Operating income2,1762,7292,3312,262
Interest income (expense), net non-operating-288-282-268-171
Gain (loss) on sale of assets--------
Other--------
Income before tax1,8932,4532,0702,096
Income after tax1,1471,5001,2371,272
Income tax, total746953833824
Net income1,1461,4981,2461,272
Total adjustments to net income-6------
Net income before extra. items1,1461,4991,2361,272
Minority interest-1-1-1--
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items1,1401,4991,2361,272
Inc. avail. to common incl. extra. items1,1401,4981,2461,272
Diluted net income1,1401,4981,2461,272
Dilution adjustment--------
Diluted weighted average shares1,0991,1141,1211,132
Diluted EPS excluding extraordinary itemsvalue per share1.041.351.101.12
Dividends per sharevalue per share0.430.350.350.35
Diluted normalized EPSvalue per share1.041.351.101.12